Full metadata record

DC Field Value Language
dc.contributor.authorYang, Hyun-Mo-
dc.contributor.authorShin, Hye-Rim-
dc.contributor.authorCho, Soo-Hyun-
dc.contributor.authorBang, Seong-Cheol-
dc.contributor.authorSong, Gyu-Yong-
dc.contributor.authorJu, Jung-Hun-
dc.contributor.authorKim, Mi-Kyeong-
dc.contributor.authorLee, Seung-Ho-
dc.contributor.authorRyu, Jae-Chun-
dc.contributor.authorKim, Youngsoo-
dc.contributor.authorJung, Sang-Hun-
dc.date.accessioned2024-01-21T01:35:02Z-
dc.date.available2024-01-21T01:35:02Z-
dc.date.created2021-09-04-
dc.date.issued2007-01-01-
dc.identifier.issn0968-0896-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/134751-
dc.description.abstractNovel chalcones were found as potent inhibitors of interleukin (IL)-5. 1-(2-Benzyloxy-6-hydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one (2b, 78.8% inhibition at 50 mu M, IC50 = 25.3 mu M) was initially identified as a potent inhibitor of IL-5. This shows the compatible activity with budesonide or sophoricoside. To identify structural requirements, 26 chalcones were prepared and their inhibitory activities were tested against IL-5. Among them, compound 4-[(E)-3-(2-cyclohexylmethoxy-6-hydroxyphenyl)-3-oxoprop-1-enyl]benzenesulfonamide (2w, 99.5% inhibition at 50 mu M, IC50 = 1-8 mu M) shows the most potent activity. The important structural requirements of these chalcone analogs exhibiting the inhibitory activity against IL-5 were recognized as the following. (1) The hydrophobic group such as benzyloxy or cyclohexylmethoxy at 6-position of A ring is necessary. (2) The existence of phenolic hydroxyl at 6-position of A ring is critical. (3) Propenone unit as alpha,beta-unsaturated ketone is essential. (4) Electron withdrawing groups with hydrogen acceptor property at 4-position of B ring enhance the activity and quantitative structure-activity relationship of 2 regarding these substituents was determined. (c) 2006 Elsevier Ltd. All rights reserved.-
dc.languageEnglish-
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD-
dc.subjectAIRWAY HYPERRESPONSIVENESS-
dc.subjectSOPHORICOSIDE ANALOGS-
dc.subjectMOLECULAR-CLONING-
dc.subjectIL-5-
dc.subjectEOSINOPHILIA-
dc.subjectEXPRESSION-
dc.subjectHYPERREACTIVITY-
dc.subjectRECEPTORS-
dc.subjectBINDING-
dc.subjectLEADS-
dc.titleStructural requirement of chalcones for the inhibitory activity of interleukin-5-
dc.typeArticle-
dc.identifier.doi10.1016/j.bmc.2006.10.007-
dc.description.journalClass1-
dc.identifier.bibliographicCitationBIOORGANIC & MEDICINAL CHEMISTRY, v.15, no.1, pp.104 - 111-
dc.citation.titleBIOORGANIC & MEDICINAL CHEMISTRY-
dc.citation.volume15-
dc.citation.number1-
dc.citation.startPage104-
dc.citation.endPage111-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000243087200009-
dc.identifier.scopusid2-s2.0-33750944756-
dc.relation.journalWebOfScienceCategoryBiochemistry & Molecular Biology-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalWebOfScienceCategoryChemistry, Organic-
dc.relation.journalResearchAreaBiochemistry & Molecular Biology-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalResearchAreaChemistry-
dc.type.docTypeArticle-
dc.subject.keywordPlusAIRWAY HYPERRESPONSIVENESS-
dc.subject.keywordPlusSOPHORICOSIDE ANALOGS-
dc.subject.keywordPlusMOLECULAR-CLONING-
dc.subject.keywordPlusIL-5-
dc.subject.keywordPlusEOSINOPHILIA-
dc.subject.keywordPlusEXPRESSION-
dc.subject.keywordPlusHYPERREACTIVITY-
dc.subject.keywordPlusRECEPTORS-
dc.subject.keywordPlusBINDING-
dc.subject.keywordPlusLEADS-
dc.subject.keywordAuthorchalcones-
dc.subject.keywordAuthorinhibitor-
dc.subject.keywordAuthorSAR-
dc.subject.keywordAuthorinterleukin-5-
Appears in Collections:
KIST Article > 2007
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE